Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Starr Christopher M, Director. Insider active across 1 company, notably Monopar Therapeutics. Cumulatively, 12 disclosures have been logged. Activity tracked since 14 July 2025. The latest transaction was filed on 14 July 2025 (X). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
STARR CHRISTOPHER M is Administrateur at Monopar Therapeutics (XNAS). He has 12 filings in total, and the sampled recent filings cover the period from 2021-07-02 to 2025-07-16. The most common transaction nature is Levée d'options, and the buy and sell volumes shown for this recent sample are EUR 0 and EUR 0.